MCID: CLC043
MIFTS: 16

Celiac Disease 11

Categories: Genetic diseases, Gastrointestinal diseases, Rare diseases, Immune diseases

Aliases & Classifications for Celiac Disease 11

MalaCards integrated aliases for Celiac Disease 11:

Name: Celiac Disease 11 54
Celiac Disease, Susceptibility to, 11 13

Classifications:



External Ids:

OMIM 54 612009

Summaries for Celiac Disease 11

OMIM : 54
Celiac disease, also known as celiac sprue and gluten-sensitive enteropathy, is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins (summary by Farrell and Kelly, 2002). For additional information and a discussion of genetic heterogeneity of celiac disease, see 212750. (612009)

MalaCards based summary : Celiac Disease 11, is also known as celiac disease, susceptibility to, 11. An important gene associated with Celiac Disease 11 is CELIAC11 (Celiac Disease, Susceptibility To, 11). The drugs Capecitabine and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include small intestine, liver and colon.

Related Diseases for Celiac Disease 11

Symptoms & Phenotypes for Celiac Disease 11

Clinical features from OMIM:

612009

Drugs & Therapeutics for Celiac Disease 11

Drugs for Celiac Disease 11 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Capecitabine Approved, Investigational Phase 2, Phase 3 154361-50-9 60953
2
Cisplatin Approved Phase 2, Phase 3 15663-27-1 84093 441203 2767
3
Doxorubicin Approved, Investigational Phase 2, Phase 3 23214-92-8 31703
4
Ethiodized oil Approved Phase 2, Phase 3 8008-53-5
5
Pancrelipase Approved Phase 3 53608-75-6
6
Doxil Approved June 1999 Phase 2, Phase 3 31703
7 Anesthetics Phase 2, Phase 3
8 pancreatin Phase 3
9 Hematinics Phase 3
10 Liver Extracts Phase 3
11 Pharmaceutical Solutions Phase 3
12 Barley Approved, Nutraceutical
13 Cassava Nutraceutical
14 Cola Nutraceutical

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma Unknown status NCT00522405 Phase 2, Phase 3
2 Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail Recruiting NCT02117895 Phase 3
3 Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation Recruiting NCT02584283 Phase 3 Glutathione
4 Comparison of the Laparoscopy-Assisted Distal Gastrectomy and Open Distal Gastrectomy for Advanced Gastric Cancer Unknown status NCT00741676 Phase 1
5 Risk of Celiac Disease and Age at Gluten Introduction Completed NCT00639444
6 Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls Completed NCT02171403
7 Non-Celiac Wheat Sensitivity: Permanent or Transient Condition? Completed NCT02823522
8 Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy Recruiting NCT02432794

Search NIH Clinical Center for Celiac Disease 11

Genetic Tests for Celiac Disease 11

Anatomical Context for Celiac Disease 11

MalaCards organs/tissues related to Celiac Disease 11:

39
Small Intestine, Liver, Colon

Publications for Celiac Disease 11

Variations for Celiac Disease 11

Expression for Celiac Disease 11

Search GEO for disease gene expression data for Celiac Disease 11.

Pathways for Celiac Disease 11

GO Terms for Celiac Disease 11

Sources for Celiac Disease 11

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....